Home/Filings/4/0001415889-24-001541
4//SEC Filing

WOODHOUSE DAVID J 4

Accession 0001415889-24-001541

CIK 0001426332other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 6:01 PM ET

Size

5.7 KB

Accession

0001415889-24-001541

Insider Transaction Report

Form 4
Period: 2024-01-16
WOODHOUSE DAVID J
DirectorCEO and acting CFO
Transactions
  • Tax Payment

    Common Stock

    2024-01-16$1.34/sh13,032$17,463131,822 total
Holdings
  • Common Stock

    (indirect: See footnote)
    80,000
Footnotes (2)
  • [F1]Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
  • [F2]Shares held by The Woodhouse Family Trust 9/8/05.

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1
  • filerCIK 0001642995

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:01 PM ET
Size
5.7 KB